Rallybio Corp reveals merger with Avenzo Therapeutics set to close on November 20, 2026, along with a special cash distribution of $13.90 per share.
| Name | Rallybio Corp |
|---|---|
| CIK | 0001739410 |
| Tickers | RLYB |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 851083789 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 203- 859-3820 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Rallybio Corp reveals merger with Avenzo Therapeutics set to close on November 20, 2026, along with a special cash distribution of $13.90 per share.
Rallybio Corp will execute a one-for-two reverse stock split in connection with its merger with Avenzo Therapeutics, effective November 20, 2026.
Rallybio Corp reveals a one-for-two reverse stock split in connection with its merger with Avenzo Therapeutics, effective November 20, 2026.
Rallybio Corp postpones merger with Avenzo Therapeutics, affecting cash distribution plans amid regulatory challenges.
Rallybio Corp delays merger closing with Avenzo Therapeutics due to unmet listing conditions, impacting cash distributions to shareholders.
Rallybio Corp's annual meeting approves merger proposals with Avenzo Therapeutics, including a new equity plan and name change, signaling a strategic shift.
Jonathan Lieber, CFO of Rallybio Corp, acquired 7,124 shares of common stock, signaling confidence in the company's future.
Rallybio Corp's CFO Jonathan Lieber discloses significant stock transactions, reflecting the company's commitment to aligning executive interests with shareholder value.
Rallybio Corp's Ronald Hunt acquires over 12,000 shares, signaling confidence in the company's future in the pharmaceutical preparations industry.
Christine A. Nash, a director at Rallybio Corp, acquires 3,562 shares at $2.38 each, signaling confidence in the company's future.
Rallybio Corp's CEO Stephen Uden acquires 33,244 shares at $6.08 each, signaling confidence in the company's future and impacting the pharmaceutical preparations sector.
Rallybio Corp's Q3 results show strategic advancements in R&D, impacting the pharmaceutical preparations sector and signaling future growth opportunities.
Rallybio Corp has filed a prospectus related to a business combination, marking a strategic move in the pharmaceutical preparations industry.
Rallybio Corp announces an $82.7 million cash distribution to shareholders in connection with its merger with Avenzo Therapeutics, set for November 2026.
Rallybio Corp's Paula Soteropoulos acquired shares, signaling confidence in the company's growth within the pharmaceutical preparations sector.
Rallybio Corp's director Helen Boudreau acquires shares, signaling confidence in the company's future and the pharmaceutical industry.
Rallybio Corp's director Robert Lorne Hopfner acquires shares and options, indicating confidence in the company's direction and potential growth.
Rallybio Corp's CEO Stephen Uden acquires 22,456 shares, signaling confidence in the pharmaceutical sector's growth potential.
314 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 425 | 425 | 0001193125-26-458630 | 001-40693 | 261547786 | 34 | 25499 | |||
| 2026-11-12 | 8-K | 8-K | 8.01 | 0001193125-26-458624 | 001-40693 | 261547771 | 34 | 147695 | 1 | 1 |
| 2026-11-10 | 425 | 425 | 0001193125-26-455769 | 001-40693 | 261541667 | 34 | 49341 | |||
| 2026-11-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-455762 | 001-40693 | 261541596 | 34 | 179007 | 1 | 1 |
| 2026-11-06 | 425 | 425 | 0001193125-26-452121 | 001-40693 | 261533105 | 34 | 18301 | |||
| 2026-11-06 | 8-K | 8-K | 8.01 | 0001193125-26-452115 | 001-40693 | 261533093 | 34 | 138011 | 1 | 1 |
| 2026-11-05 | 4 | 4 | 0001193125-26-450103 | 14457 | ||||||
| 2026-11-05 | 4 | 4 | 0001193125-26-450102 | 7090 | ||||||
| 2026-11-04 | 8-K | 8-K | 5.02,5.07,8.01,9.01 | 0001193125-26-447550 | 001-40693 | 261523515 | 34 | 200340 | 1 | 1 |
| 2026-11-03 | 4 | 4 | 0001193125-26-445701 | 6922 | ||||||
| 2026-11-02 | 4 | 4 | 0001193125-26-443915 | 10538 | ||||||
| 2026-11-02 | 4 | 4 | 0001193125-26-443898 | 14199 | ||||||
| 2026-10-30 | 4 | 4 | 0001193125-26-441964 | 6853 | ||||||
| 2026-10-29 | 4 | 4 | 0001193125-26-438086 | 6846 | ||||||
| 2026-10-28 | 4 | 4 | 0001193125-26-436314 | 6257 | ||||||
| 2026-10-28 | 4 | 4 | 0001193125-26-436313 | 6823 | ||||||
| 2026-10-27 | 10-Q | 10-Q | 0001628280-26-067422 | 001-40693 | 261487396 | 34 | 6064952 | 1 | 1 | |
| 2026-10-26 | 425 | 425 | 0001193125-26-432123 | 001-40693 | 261486533 | 34 | 31790 | |||
| 2026-10-26 | 8-K | 8-K | 8.01 | 0001193125-26-432114 | 001-40693 | 261486503 | 34 | 156085 | 1 | 1 |
| 2026-10-20 | 4 | 4 | 0001193125-26-426875 | 6804 | ||||||
| 2026-10-20 | 4 | 4 | 0001193125-26-426872 | 6851 | ||||||
| 2026-10-15 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003252 | 333-297483 | 261464242 | 33 | 1834 | ||
| 2026-10-15 | 424B3 | 424B3 | 0001193125-26-422924 | 333-297483 | 261463358 | 33 | 13049847 | |||
| 2026-10-14 | S-4/A | S-4/A NO. 4 | 0001193125-26-421809 | 333-297483 | 261460567 | 33 | 13170928 | |||
| 2026-10-14 | 4 | 4 | 0001193125-26-421747 | 14223 | ||||||
| 2026-10-13 | 4 | 4 | 0001193125-26-420562 | 6871 | ||||||
| 2026-10-08 | 4 | 4 | 0001193125-26-418051 | 6886 | ||||||
| 2026-10-05 | S-4/A | S-4/A NO. 3 | 0001193125-26-412774 | 333-297483 | 261438493 | 33 | 13235901 | |||
| 2026-10-01 | 4 | 4 | 0001193125-26-410885 | 6873 | ||||||
| 2026-09-28 | 4 | 4 | 0001193125-26-405753 | 10358 | ||||||
| 2026-09-18 | 4 | 4 | 0001193125-26-395755 | 6572 | ||||||
| 2026-09-16 | S-4/A | S-4/A NO. 2 | 0001193125-26-392246 | 333-297483 | 261382070 | 33 | 13259908 | |||
| 2026-09-09 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-386511 | 001-40693 | 261368491 | 34 | 167183 | 1 | 1 |
| 2026-08-26 | S-4/A | S-4/A | 0001193125-26-368568 | 333-297483 | 261323263 | 33 | 28283980 | 1 | 1 | |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097296 | 005-92742 | 261283084 | 34 | 11052 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003694 | 005-92742 | 261279720 | 34 | 9651 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003435 | 005-92742 | 261275845 | 34 | 13606 | |||
| 2026-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002189 | 005-92742 | 261247384 | 34 | 11616 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001628280-26-053880 | 001-40693 | 261246123 | 34 | 6055363 | 1 | 1 | |
| 2026-08-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001390202-26-000012 | 005-92742 | 261238444 | 34 | 11255 | |||
| 2026-07-15 | S-4 | S-4 | 0001193125-26-304966 | 333-297483 | 261178113 | 33 | 30268499 | 1 | 1 | |
| 2026-07-10 | 4 | 4 | 0001193125-26-300913 | 6600 | ||||||
| 2026-06-05 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-071013 | 005-92742 | 261069698 | 34 | 14622 | |||
| 2026-06-01 | 425 | 425 | 0001193125-26-249801 | 001-40693 | 261047299 | 34 | 16266076 | |||
| 2026-06-01 | 8-K | 8-K | 1.01,3.02,5.01,5.02,7.01,9.01 | 0001193125-26-249790 | 001-40693 | 261047288 | 34 | 16757593 | 1 | 1 |
| 2026-05-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-064729 | 12110 | ||||||
| 2026-05-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-062883 | 13276 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000905148-26-002426 | 005-92742 | 26990056 | 34 | 31123 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062682 | 005-92742 | 26988817 | 34 | 10850 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002223 | 005-92742 | 26985295 | 34 | 10849 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-225116 | 005-92742 | 26981925 | 34 | 126337 | |||
| 2026-05-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-060513 | 13805 | ||||||
| 2026-05-13 | 10-Q | 10-Q | 0001628280-26-034580 | 001-40693 | 26973097 | 34 | 5314293 | 1 | 1 | |
| 2026-05-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-056540 | 12665 | ||||||
| 2026-05-06 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-056538 | 6736 | ||||||
| 2026-05-06 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001674324-26-000004 | 005-92742 | 26949396 | 34 | 17674 | |||
| 2026-05-05 | RW | RW | 0001193125-26-206462 | 333-294361 | 26943390 | NE | 8119 | |||
| 2026-05-04 | 8-K | 8-K | 1.02,9.01 | 0001193125-26-202601 | 001-40693 | 26934673 | 34 | 158845 | 1 | 1 |
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001390202-26-000007 | 005-92742 | 26911863 | 34 | 11534 | |||
| 2026-04-24 | S-4/A | S-4/A NO. 1 | 0001193125-26-177461 | 333-294361 | 26894930 | 33 | 10635423 | |||
| 2026-04-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000904454-26-000233 | 005-92742 | 26856894 | 34 | 9905 | |||
| 2026-03-31 | 8-K | 8-K | 5.02 | 0001628280-26-022385 | 001-40693 | 26821766 | 34 | 145423 | 1 | 1 |
| 2026-03-17 | S-4 | S-4 | 0001193125-26-108699 | 333-294361 | 26758206 | 33 | 23741223 | 1 | 1 | |
| 2026-03-16 | 10-K | 10-K | 0001628280-26-018261 | 001-40693 | 26757951 | 34 | 9082287 | 1 | 1 | |
| 2026-03-10 | 3 | 3 | 0001193125-26-099788 | 5719 | ||||||
| 2026-03-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000665 | 005-92742 | 26728990 | 34 | 11270 | |||
| 2026-03-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000664 | 005-92742 | 26728976 | 34 | 11225 | |||
| 2026-03-03 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001999371-26-004957 | 005-92742 | 26715148 | 34 | 21915 | |||
| 2026-03-02 | 425 | 425 | 0001193125-26-084452 | 001-40693 | 26703966 | 34 | 5918244 | |||
| 2026-03-02 | 8-K | 8-K | 1.01,3.02,5.01,5.02,7.01,9.01 | 0001193125-26-084444 | 001-40693 | 26703918 | 34 | 6396984 | 1 | 1 |
| 2026-02-27 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001674324-26-000002 | 005-92742 | 26701061 | 34 | 18250 | |||
| 2026-02-23 | 4 | FORM 4 | 0001739410-26-000022 | 6228 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001628280-26-010334 | 5607 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001739410-26-000015 | 5601 | ||||||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000905148-26-000885 | 005-92742 | 26642029 | 34 | 34920 | |||
| 2026-01-29 | 8-K | 8-K | 5.03,5.07,9.01 | 0001739410-26-000010 | 001-40693 | 26579290 | 34 | 174341 | 1 | 1 |
| 2026-01-02 | DEF 14A | DEF 14A | 0001140361-26-000191 | 001-40693 | 26502391 | 34 | 1718301 | |||
| 2025-12-23 | PRE 14A | PRE 14A | 0001140361-25-046536 | 001-40693 | 251600416 | 34 | 1718345 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001739410-25-000132 | 001-40693 | 251456297 | 34 | 6033954 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001739410-25-000131 | 001-40693 | 251456287 | 34 | 235418 | 1 | 1 |
| 2025-08-29 | 8-K | 8-K | 3.01,9.01 | 0001193125-25-192749 | 001-40693 | 251280815 | 34 | 144074 | 1 | 1 |
| 2025-08-07 | 10-Q | 10-Q | 0001739410-25-000112 | 001-40693 | 251191807 | 34 | 5670097 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0001739410-25-000108 | 001-40693 | 251191751 | 34 | 241445 | 1 | 1 |
| 2025-07-08 | 8-K | 8-K | 1.01,2.01,8.01,9.01 | 0001739410-25-000100 | 001-40693 | 251109554 | 34 | 173752 | 1 | 1 |
| 2025-06-27 | 8-K | 8-K | 5.02,9.01 | 0001739410-25-000093 | 001-40693 | 251086385 | 34 | 302600 | 1 | 1 |
| 2025-05-16 | 8-K | 8-K | 5.07 | 0001739410-25-000089 | 001-40693 | 25957048 | 34 | 159872 | 1 | 1 |
| 2025-05-15 | 4 | FORM 4 | 0001739410-25-000087 | 5414 | ||||||
| 2025-05-15 | 4 | FORM 4 | 0001739410-25-000086 | 5405 | ||||||
| 2025-05-15 | 4 | FORM 4 | 0001739410-25-000085 | 5426 | ||||||
| 2025-05-15 | 4 | FORM 4 | 0001739410-25-000084 | 5437 | ||||||
| 2025-05-15 | 4 | FORM 4 | 0001739410-25-000083 | 5450 | ||||||
| 2025-05-15 | 4 | FORM 4 | 0001739410-25-000082 | 5388 | ||||||
| 2025-05-15 | 4 | FORM 4 | 0001739410-25-000081 | 5391 | ||||||
| 2025-05-15 | 4 | FORM 4 | 0001739410-25-000080 | 5428 | ||||||
| 2025-05-09 | S-8 | S-8 | 0001739410-25-000069 | 333-287143 | 25930382 | 33 | 88790 | |||
| 2025-05-08 | 10-Q | 10-Q | 0001739410-25-000061 | 001-40693 | 25924025 | 34 | 5240506 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,9.01 | 0001739410-25-000059 | 001-40693 | 25924012 | 34 | 231071 | 1 | 1 |
| 2025-04-08 | 8-K | 8-K | 8.01,9.01 | 0001739410-25-000052 | 001-40693 | 25820367 | 34 | 188660 | 1 | 1 |
| 2025-04-07 | DEF 14A | DEF 14A | 0001739410-25-000045 | 001-40693 | 25818696 | 34 | 765523 | |||
| 2025-03-13 | 8-K | 8-K | 8.01,9.01 | 0001739410-25-000041 | 001-40693 | 25736524 | 34 | 207335 | 1 | 1 |
| 2025-03-13 | 424B5 | 424B5 | 0001193125-25-053960 | 333-266668 | 25736342 | 33 | 271739 | |||
| 2025-03-13 | 10-K | 10-K | 0001739410-25-000040 | 001-40693 | 25735745 | 34 | 9260439 | 1 | 1 | |
| 2025-03-13 | 8-K | 8-K | 2.02,9.01 | 0001739410-25-000029 | 001-40693 | 25733899 | 34 | 255039 | 1 | 1 |
| 2025-02-25 | 8-K | 8-K | 3.01 | 0001739410-25-000021 | 001-40693 | 25664172 | 34 | 156878 | 1 | 1 |
| 2025-02-19 | 4 | FORM 4 | 0001739410-25-000014 | 5429 | ||||||
| 2025-02-19 | 4 | FORM 4 | 0001739410-25-000013 | 5436 | ||||||
| 2025-02-19 | 4 | FORM 4 | 0001739410-25-000012 | 5482 | ||||||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000886 | 005-92742 | 25612584 | 34 | 11330 | |||
| 2025-01-06 | 4 | FORM 4 | 0001739410-25-000008 | 5614 | ||||||
| 2025-01-06 | 4 | FORM 4 | 0001739410-25-000007 | 5612 | ||||||
| 2025-01-06 | 4 | FORM 4 | 0001739410-25-000006 | 5636 | ||||||
| 2025-01-06 | 4 | FORM 4 | 0001739410-25-000005 | 5577 | ||||||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002857 | 005-92742 | 241444935 | 34 | 7828 | |||
| 2024-11-07 | 10-Q | 10-Q | 0001739410-24-000136 | 001-40693 | 241435657 | 34 | 5341619 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0001739410-24-000132 | 001-40693 | 241433311 | 34 | 264098 | 1 | 1 |
| 2024-09-17 | 8-K | 8-K | 5.02 | 0001739410-24-000121 | 001-40693 | 241302639 | 34 | 153569 | 1 | 1 |
| 2024-08-08 | 10-Q | 10-Q | 0001739410-24-000115 | 001-40693 | 241186181 | 34 | 6029939 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0001739410-24-000114 | 001-40693 | 241186164 | 34 | 257218 | 1 | 1 |
| 2024-07-30 | SC 13G | rallybiosch13gforjjdc.htm | 0000904454-24-000439 | 005-92742 | 241159603 | 34 | 48866 | |||
| 2024-07-30 | SC 13G/A | SC 13G/A | 0001193125-24-188672 | 005-92742 | 241156077 | 34 | 64549 | |||
| 2024-07-23 | 8-K | 8-K | 5.02,9.01 | 0001739410-24-000105 | 001-40693 | 241134522 | 34 | 208293 | 1 | 1 |
| 2024-05-21 | 8-K | 8-K | 5.07 | 0001739410-24-000098 | 001-40693 | 24969673 | 34 | 162010 | 1 | 1 |
| 2024-05-20 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-05-20 16:00:00 | 9999999995-24-001593 | 333-279317 | 24966728 | 33 | 1840 | ||
| 2024-05-17 | 4 | FORM 4 | 0001739410-24-000094 | 5433 | ||||||
| 2024-05-17 | 4 | FORM 4 | 0001739410-24-000093 | 5421 | ||||||
| 2024-05-17 | 4 | FORM 4 | 0001739410-24-000092 | 5398 | ||||||
| 2024-05-17 | 4 | FORM 4 | 0001739410-24-000091 | 5426 | ||||||
| 2024-05-17 | 4 | FORM 4 | 0001739410-24-000090 | 5395 | ||||||
| 2024-05-17 | 4 | FORM 4 | 0001739410-24-000089 | 5444 | ||||||
| 2024-05-17 | 4 | FORM 4 | 0001739410-24-000088 | 5457 | ||||||
| 2024-05-17 | 4 | FORM 4 | 0001739410-24-000087 | 5412 | ||||||
| 2024-05-16 | CORRESP | filename1.htm | 0001193125-24-140422 | 6982 | ||||||
| 2024-05-16 | UPLOAD | filename1.pdf | 0000000000-24-005640 | 333-279317 | 40363 | |||||
| 2024-05-10 | S-3 | S-3 | 0001193125-24-136133 | 333-279317 | 24934662 | 33 | 481654 | |||
| 2024-05-09 | 10-Q | 10-Q | 0001739410-24-000057 | 001-40693 | 24930609 | 34 | 4636197 | 1 | 1 | |
| 2024-05-09 | 8-K | 8-K | 2.02,9.01 | 0001739410-24-000053 | 001-40693 | 24928709 | 34 | 231927 | 1 | 1 |
| 2024-04-22 | D | xslFormDX01/primary_doc.xml | 06b | 0001739410-24-000047 | 021-511203 | 24860890 | 33 | 15596 | ||
| 2024-04-11 | DEF 14A | DEF 14A | 0001739410-24-000045 | 001-40693 | 24838594 | 34 | 793261 | |||
| 2024-04-10 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001739410-24-000040 | 001-40693 | 24835880 | 34 | 203448 | 1 | 1 |
| 2024-03-13 | S-8 | S-8 | 0001193125-24-066873 | 333-277880 | 24746446 | 33 | 57434 | |||
| 2024-03-12 | 10-K | 10-K | 0001739410-24-000035 | 001-40693 | 24742457 | 34 | 8361550 | 1 | 1 | |
| 2024-03-12 | 8-K | 8-K | 2.02,9.01 | 0001739410-24-000030 | 001-40693 | 24740262 | 34 | 257875 | 1 | 1 |
| 2024-02-16 | 4 | FORM 4 | 0001739410-24-000020 | 5403 | ||||||
| 2024-02-16 | 4 | FORM 4 | 0001739410-24-000019 | 5443 | ||||||
| 2024-02-16 | 4 | FORM 4 | 0001739410-24-000018 | 5447 | ||||||
| 2024-02-16 | 4 | FORM 4 | 0001739410-24-000017 | 5409 | ||||||
| 2024-02-14 | SC 13G/A | sayw24021417_13ga.htm | 0000905148-24-000620 | 005-92742 | 24633619 | 34 | 288570 | |||
| 2024-02-12 | SC 13D/A | SC 13D/A | 0001193125-24-032553 | 005-92742 | 24622298 | 34 | 141001 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001447 | 005-92742 | 24612083 | 34 | 7797 | |||
| 2024-02-06 | 8-K | 8-K | 2.02,2.05,9.01 | 0001739410-24-000012 | 001-40693 | 24598151 | 34 | 195916 | 1 | 1 |
| 2024-01-04 | 4 | FORM 4 | 0001739410-24-000004 | 5570 | ||||||
| 2024-01-04 | 4 | FORM 4 | 0001739410-24-000003 | 5581 | ||||||
| 2024-01-02 | SC 13G/A | SC 13G/A | 0001193125-24-000710 | 005-92742 | 24502863 | 34 | 43575 | |||
| 2023-12-20 | 8-K | 8-K | 7.01,9.01 | 0001739410-23-000019 | 001-40693 | 231499418 | 34 | 3176700 | 1 | 1 |
| 2023-11-09 | 10-Q | 10-Q | 0001739410-23-000014 | 001-40693 | 231392467 | 34 | 4469590 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0001739410-23-000011 | 001-40693 | 231390176 | 34 | 250372 | 1 | 1 |
| 2023-08-08 | 10-Q | 10-Q | 0001739410-23-000007 | 001-40693 | 231151631 | 34 | 16823567 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0001739410-23-000004 | 001-40693 | 231149458 | 34 | 250460 | 1 | 1 |
| 2023-06-29 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-030535 | 001-40693 | 231054312 | 34 | 268364 | 1 | 1 |
| 2023-05-22 | 8-K | 8-K | 5.07 | 0000950170-23-023468 | 001-40693 | 23944938 | 34 | 199181 | 1 | 1 |
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013407 | 5427 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013406 | 5445 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013405 | 5422 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013404 | 5458 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013402 | 5396 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013398 | 5399 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013396 | 5434 | ||||||
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013393 | 5413 | ||||||
| 2023-05-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-05-12 16:00:00 | 9999999995-23-001418 | 333-271748 | 23918043 | 33 | 1760 | ||
| 2023-05-12 | 424B3 | 424B3 | 0001193125-23-143580 | 333-271748 | 23916670 | 33 | 144037 | |||
| 2023-05-11 | CORRESP | filename1.htm | 0001193125-23-141890 | 7431 | ||||||
| 2023-05-11 | UPLOAD | filename1.pdf | 0000000000-23-004995 | 40214 | ||||||
| 2023-05-10 | S-8 | S-8 | 0001193125-23-140753 | 333-271805 | 23906722 | 33 | 63242 | |||
| 2023-05-09 | S-3 | S-3 | 0001193125-23-138977 | 333-271748 | 23900171 | 33 | 252569 | |||
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019165 | 001-40693 | 23900099 | 34 | 6737979 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-019161 | 001-40693 | 23900082 | 34 | 354852 | 1 | 1 |
| 2023-04-10 | DEF 14A | DEF 14A | 0000950170-23-012313 | 001-40693 | 23811759 | 34 | 1381309 | |||
| 2023-03-16 | 4 | 4 | 0000950170-23-008553 | 5048 | ||||||
| 2023-03-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-017538 | 6484 | ||||||
| 2023-03-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-017533 | 11715 | ||||||
| 2023-03-06 | 10-K | 10-K | 0000950170-23-006264 | 001-40693 | 23709350 | 34 | 15300398 | 1 | 1 | |
| 2023-03-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-006125 | 001-40693 | 23707663 | 34 | 537928 | 1 | 1 |
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001356 | 005-92742 | 23601212 | 34 | 7715 | |||
| 2023-02-06 | 4 | FORM 4 SUBMISSION | 0000899243-23-004078 | 5439 | ||||||
| 2023-02-06 | 4 | FORM 4 SUBMISSION | 0000899243-23-004077 | 5408 | ||||||
| 2023-02-06 | 4 | FORM 4 SUBMISSION | 0000899243-23-004074 | 5451 | ||||||
| 2023-02-06 | SC 13G/A | SC 13G/A | 0001193125-23-025652 | 005-92742 | 23591137 | 34 | 144343 | |||
| 2023-02-01 | 4 | FORM 4 SUBMISSION | 0000899243-23-003156 | 5512 | ||||||
| 2023-02-01 | 3 | FORM 3 SUBMISSION | 0000899243-23-003154 | 7097 | ||||||
| 2023-02-01 | SC 13G/A | SC 13G/A | 0001193125-23-021617 | 005-92742 | 23577229 | 34 | 63400 | |||
| 2023-01-31 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-001474 | 001-40693 | 23572764 | 34 | 241192 | 1 | 1 |
| 2023-01-23 | SC 13G/A | SC 13G/A | 0001104659-23-005733 | 005-92742 | 23543478 | 34 | 56342 | |||
| 2023-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-001049 | 5322 | ||||||
| 2023-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-001048 | 5354 | ||||||
| 2023-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-001046 | 5333 | ||||||
| 2023-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-001044 | 5361 | ||||||
| 2022-12-01 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-295957 | 001-40693 | 221437424 | 34 | 174690 | 1 | 1 |
| 2022-11-17 | 4 | xslF345X03/form4.xml | 0001140361-22-042081 | 18728 | ||||||
| 2022-11-17 | SC 13G | SC 13G | 0001193125-22-287471 | 005-92742 | 221397535 | 34 | 41264 | |||
| 2022-11-14 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-284569 | 001-40693 | 221385383 | 34 | 688948 | 1 | 1 |
| 2022-11-14 | 424B5 | 424B5 | 0001193125-22-283756 | 333-266668 | 221380447 | 33 | 399409 | |||
| 2022-11-10 | 424B5 | 424B5 | 0001193125-22-282070 | 333-266668 | 221375308 | 33 | 406148 | |||
| 2022-11-07 | 10-Q | 10-Q | 0000950170-22-022342 | 001-40693 | 221363859 | 34 | 8181168 | 1 | 1 | |
| 2022-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-022335 | 001-40693 | 221363788 | 34 | 441255 | 1 | 1 |
| 2022-09-28 | 8-K | 8-K | 7.01,9.01 | 0000950170-22-018936 | 001-40693 | 221272836 | 34 | 230519 | 1 | 1 |
| 2022-08-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-08-15 16:00:00 | 9999999995-22-002385 | 333-266668 | 221168339 | 33 | 1761 | ||
| 2022-08-15 | 424B5 | 424B5 | 0001193125-22-221342 | 333-266668 | 221167138 | 33 | 245581 | |||
| 2022-08-11 | CORRESP | filename1.htm | 0001193125-22-218532 | 6266 | ||||||
| 2022-08-11 | UPLOAD | filename1.pdf | 0000000000-22-008535 | 40199 | ||||||
| 2022-08-08 | S-3 | S-3 | 0001193125-22-215079 | 333-266668 | 221145550 | 33 | 583756 | |||
| 2022-08-08 | 10-Q | 10-Q | 0000950170-22-015571 | 001-40693 | 221144896 | 34 | 8029308 | 1 | 1 | |
| 2022-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-015259 | 001-40693 | 221142684 | 34 | 426208 | 1 | 1 |
| 2022-08-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-027631 | 5343 | ||||||
| 2022-08-03 | 3 | FORM 3 SUBMISSION | 0000899243-22-027628 | 7042 | ||||||
| 2022-08-02 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-22-013744 | 001-40693 | 221126963 | 34 | 217935 | 1 | 1 |
| 2022-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-034860 | 7462 | ||||||
| 2022-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-034858 | 15919 | ||||||
| 2022-06-07 | SC 13D/A | SC 13D/A | 0001104659-22-068929 | 005-92742 | 221001212 | 34 | 149715 | |||
| 2022-06-06 | S-8 | S-8 | 0001193125-22-168379 | 333-265443 | 22998471 | 33 | 63925 | |||
| 2022-06-02 | 8-K | 8-K | 5.02,9.01 | 0000950170-22-011050 | 001-40693 | 22989347 | 34 | 210512 | 1 | 1 |
| 2022-05-27 | 8-K | 8-K | 5.07 | 0000950170-22-010851 | 001-40693 | 22977184 | 34 | 193814 | 1 | 1 |
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-019835 | 5365 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-019834 | 5365 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-019832 | 5403 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-019830 | 5391 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-019829 | 5427 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-019828 | 5410 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-019827 | 5415 | ||||||
| 2022-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-031969 | 7461 | ||||||
| 2022-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-031966 | 15913 | ||||||
| 2022-05-10 | 10-Q | 10-Q | 0000950170-22-009013 | 001-40693 | 22910270 | 34 | 6473061 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 1.01,2.02,8.01,9.01 | 0000950170-22-008944 | 001-40693 | 22909412 | 34 | 379395 | 1 | 1 |
| 2022-04-25 | DEF 14A | DEF 14A | 0000950170-22-006110 | 001-40693 | 22850484 | 34 | 1137116 | |||
| 2022-04-06 | 4 | FORM 4 SUBMISSION | 0000899243-22-014169 | 5377 | ||||||
| 2022-04-06 | 4 | FORM 4 SUBMISSION | 0000899243-22-014167 | 5331 | ||||||
| 2022-04-06 | 3 | FORM 3 SUBMISSION | 0000899243-22-014165 | 7219 | ||||||
| 2022-04-06 | 3 | FORM 3 SUBMISSION | 0000899243-22-014163 | 7286 | ||||||
| 2022-04-04 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-22-005307 | 001-40693 | 22800458 | 34 | 216318 | 1 | 1 |
| 2022-03-23 | 4 | FORM 4 SUBMISSION | 0000899243-22-011950 | 8135 | ||||||
| 2022-03-15 | 10-K | 10-K | 0000950170-22-003767 | 001-40693 | 22741578 | 34 | 11441876 | 1 | 1 | |
| 2022-03-15 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-003666 | 001-40693 | 22739220 | 34 | 375639 | 1 | 1 |
| 2022-03-07 | 8-K | 8-K | 7.01,9.01 | 0000950170-22-002960 | 001-40693 | 22716306 | 34 | 3022208 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001140361-22-005364 | 005-92742 | 22634233 | 34 | 283674 | |||
| 2022-02-11 | SC 13G | SC 13G | 0001193125-22-037232 | 005-92742 | 22621982 | 34 | 164365 | |||
| 2022-02-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-008584 | 15886 | ||||||
| 2022-02-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-008579 | 7456 | ||||||
| 2022-02-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-005526 | 5414 | ||||||
| 2022-02-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-005521 | 5437 | ||||||
| 2022-02-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-005519 | 5445 | ||||||
| 2022-02-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-005518 | 5406 | ||||||
| 2022-02-08 | SC 13G | SC 13G | 0001193125-22-030786 | 005-92742 | 22600359 | 34 | 80313 | |||
| 2022-01-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-002911 | 8126 | ||||||
| 2022-01-21 | SC 13G | SC 13G | 0001104659-22-006354 | 005-92742 | 22544928 | 34 | 56345 | |||
| 2022-01-18 | SC 13D/A | AMENDED SCHEDULE 13D | 0001387131-22-000436 | 005-92742 | 22536059 | 34 | 129100 | |||
| 2022-01-14 | 4 | FORM 4 SUBMISSION | 0000899243-22-002043 | 22481 | ||||||
| 2022-01-12 | 4 | FORM 4 SUBMISSION | 0000899243-22-001801 | 25572 | ||||||
| 2022-01-11 | 4 | FORM 4 SUBMISSION | 0000899243-22-001629 | 34724 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-001062 | 5382 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-001060 | 5358 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-001058 | 5371 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-001057 | 5357 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-001056 | 5320 | ||||||
| 2021-11-10 | 10-Q | 10-Q | 0000950170-21-004125 | 001-40693 | 211397249 | 34 | 5314588 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-003919 | 001-40693 | 211394417 | 34 | 450801 | 1 | 1 |
| 2021-09-09 | 10-Q | 10-Q | 0000950170-21-001740 | 001-40693 | 211244592 | 34 | 5996954 | 1 | 1 | |
| 2021-09-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-001739 | 001-40693 | 211244535 | 34 | 375653 | 1 | 1 |
| 2021-08-12 | SC 13D | SCHEDULE 13D | 0001387131-21-008423 | 005-92742 | 211168548 | 34 | 82252 | |||
| 2021-08-12 | SC 13D | SC 13D | 0001193125-21-244841 | 005-92742 | 211168495 | 34 | 171654 | |||
| 2021-08-12 | SC 13D | SC 13D | 0001104659-21-104153 | 005-92742 | 211167565 | 34 | 242558 | |||
| 2021-08-09 | SC 13G | SCHEDULE 13G | 0001387131-21-008259 | 005-92742 | 211156506 | 34 | 119371 | |||
| 2021-08-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-049823 | 22308 | ||||||
| 2021-08-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-049821 | 14935 | ||||||
| 2021-08-04 | 3/A | FORM 3/A SUBMISSION | 0001209191-21-049819 | 14550 | ||||||
| 2021-08-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-031635 | 12821 | ||||||
| 2021-08-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-031634 | 20135 | ||||||
| 2021-08-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-031633 | 17863 | ||||||
| 2021-08-04 | SC 13G | filing.txt | 0000315066-21-001651 | 005-92742 | 211143747 | 34 | 8185 | |||
| 2021-08-04 | 4 | PRIMARY DOCUMENT | 0000315066-21-001650 | 9312 | ||||||
| 2021-08-02 | 4 | xslF345X03/ownership.xml | 0001387131-21-007995 | 21911 | ||||||
| 2021-08-02 | S-8 | S-8 | 0001193125-21-233473 | 333-258383 | 211136980 | 33 | 73596 | |||
| 2021-08-02 | 8-K | 8-K | 1.01,3.03,5.03,9.01 | 0001193125-21-233263 | 001-40693 | 211136231 | 34 | 261694 | ||
| 2021-07-30 | 424B4 | 424B4 | 0001193125-21-230254 | 333-257655 | 211130194 | 33 | 4140049 | |||
| 2021-07-29 | 3 | xslF345X02/ownership.xml | 0001387131-21-007921 | 15636 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0001209191-21-048711 | 14161 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030703 | 8929 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030702 | 10926 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030701 | 8508 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030700 | 9007 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030695 | 9019 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030696 | 9921 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030693 | 9756 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030692 | 9755 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030690 | 10148 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030689 | 9006 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0000899243-21-030685 | 11964 | ||||||
| 2021-07-29 | 3 | PRIMARY DOCUMENT | 0000315066-21-001643 | 6614 | ||||||
| 2021-07-29 | CERT | 8A_Cert_RLYB.pdf | 0001354457-21-000871 | 001-40693 | 211124961 | 34 | 748574 | |||
| 2021-07-29 | 8-A12B | 8-A12B | 0001193125-21-228072 | 001-40693 | 211124668 | 34 | 14742 | |||
| 2021-07-28 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004408 | 271673 | ||||||
| 2021-07-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-07-28 16:00:00 | 9999999995-21-002956 | 333-257655 | 211124620 | 33 | 1761 | ||
| 2021-07-28 | S-1MEF | S-1MEF | 0001193125-21-227780 | 333-258244 | 211124444 | 33 | 55118 | |||
| 2021-07-26 | CORRESP | filename1.htm | 0001193125-21-224490 | 10450 | ||||||
| 2021-07-26 | CORRESP | filename1.htm | 0001193125-21-224489 | 6771 | ||||||
| 2021-07-22 | S-1/A | S-1/A #1 | 0001193125-21-221832 | 333-257655 | 211107634 | 33 | 6024978 | |||
| 2021-07-12 | CORRESP | filename1.htm | 0001193125-21-212796 | 61781 | ||||||
| 2021-07-02 | S-1 | S-1 | 0001193125-21-207662 | 333-257655 | 211070544 | 33 | 5174047 | |||
| 2021-06-07 | DRSLTR | filename1.htm | 0000950123-21-007614 | 31050 | ||||||
| 2021-06-07 | DRS/A | filename1.htm | 0000950123-21-007613 | 377-04734 | 211000421 | 33 | 3869653 | |||
| 2021-05-24 | UPLOAD | filename1.pdf | 0000000000-21-006487 | 49272 | ||||||
| 2021-05-13 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-002686 | 272545 | ||||||
| 2021-04-27 | DRS | filename1.htm | 0000950123-21-004979 | 377-04734 | 21860075 | 33 | 4064568 | |||
| 2020-05-29 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001739410-20-000002 | 021-364823 | 20923660 | 33 | 12898 | ||
| 2020-04-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001739410-20-000001 | 021-364823 | 20788578 | 33 | 12014 | ||
| 2018-05-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001739410-18-000001 | 021-311753 | 18809954 | 33 | 7947 |
One latest value per concept from companyfacts (227 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 5.38M | 2026-10-20 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 10.60M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-16 | 0001628280-26-018261 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 0.08 | 2026-08-26 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 0.99 | 2026-08-26 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 7,092.7 | 2026-08-26 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-26 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0.91 | 2026-08-26 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 7,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 1.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 1.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 1.47M | 2026-06-30 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 364,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 480,000 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 361.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 3.20M | 2021-08-01 | 2021-08-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003767 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 2.12M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004125 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 268,000 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 1.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | -56,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 160.31M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 |
| us-gaap | Assets | Assets | USD | 95.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 94.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 88.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 0 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 88.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 88.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 88.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001739410-24-000136 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 90.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 90.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 90.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 51.71M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022342 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -17.44M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019165 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 59.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 137.92M | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 5.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 5.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 4,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | CommonUnitAuthorized | Common Unit, Authorized | shares | 165.39M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 | |
| us-gaap | CommonUnitIssued | Common Unit, Issued | shares | 4.50M | 2018-12-31 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | 32.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003767 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003767 |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001739410-23-000014 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | investment | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001739410-25-000132 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001739410-25-000040 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 100.45M | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 25.70M | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 50.32M | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 183.30M | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 181.60M | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 301,000 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.40M | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 100.45M | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | Depreciation | Depreciation | USD | 100,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 5,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 5.73 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.48 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009013 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 5.64 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.245 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.137 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.054 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingenciesOther | Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001628280-26-018261 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.107 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | pure | -0.026 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 1.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | EquityMethodInvestmentRealizedGainLossOnDisposal | Equity Method Investment, Realized Gain (Loss) on Disposal | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022342 |
| us-gaap | FinancingReceivableAllowanceForCreditLosses | Financing Receivable, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -18,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 13.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -8.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001628280-26-018261 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -8.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001628280-26-018261 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001628280-26-018261 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | 34.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority | Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001739410-25-000040 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001739410-25-000040 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 1.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 2.20M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -1.89M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseAmortization | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount | USD | 2.31M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.23M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 17,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003767 |
| us-gaap | IncomeTaxReconciliationTaxContingenciesOther | Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount | USD | 17,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001628280-26-018261 |
| us-gaap | IncomeTaxReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount | USD | 231,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -119,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -1.23M | 2026-01-01 | 2026-06-30 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -212,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -2.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 1.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | InterestExpense | Interest Expense | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 |
| us-gaap | InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures | Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | USD | 626,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0001739410-25-000112 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 190,000 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 0 | 2021-12-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009013 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 106,000 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 156,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022342 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0001739410-24-000035 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 84,000 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 14,000 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | Liabilities | Liabilities | USD | 3.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 95.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 3.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -18,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | MembersEquity | Members' Equity | USD | -69.36M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 254,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 23.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 35.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 32.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -24.40M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 |
| us-gaap | NetRentableArea | Net Rentable Area | sqft | 4,500 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003767 | |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 51.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 18.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -17.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 176,000 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 170,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 176,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 230,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 195,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 30,000 | 2026-06-30 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | OtherAccruedLiabilitiesNoncurrent | Other Accrued Liabilities, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 2.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | OtherAssetsMiscellaneousCurrent | Other Assets, Miscellaneous, Current | USD | 300,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 810,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -18,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 390,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 678,000 | 2026-01-01 | 2026-06-30 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 762,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | OtherReceivablesGrossCurrent | Other Receivables, Gross, Current | USD | 1.00M | 2026-06-30 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | PaymentsForRent | Payments for Rent | USD | 133,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003767 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | PaymentsToAcquireEquityMethodInvestments | Payments to Acquire Equity Method Investments | USD | 300,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022342 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 100,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-08 | 0000950170-22-015571 |
| us-gaap | PaymentsToAcquireInterestInJointVenture | Payments to Acquire Interest in Joint Venture | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-13 | 0001739410-25-000040 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.08 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 4.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 593,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ProceedsFromDivestitureOfInterestInJointVenture | Proceeds from Divestiture of Interest in Joint Venture | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ProceedsFromIncomeTaxRefunds | Proceeds from Income Tax Refunds | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 13,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 23.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 241,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 16,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001628280-26-018261 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -32.08M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-08 | 0000950170-22-015571 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 503,000 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 4.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | RestructuringAndRelatedCostExpectedCost1 | Restructuring and Related Cost, Expected Cost | USD | 3.30M | 2024-03-31 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001739410-24-000136 | |
| us-gaap | RestructuringAndRelatedCostIncurredCost | Restructuring and Related Cost, Incurred Cost | USD | 1.70M | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.4 | 2025-05-02 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 837,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -269.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | Revenues | Revenues | USD | 212,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 700,000 | 2022-01-01 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022342 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 2.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 1.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-13 | 0001628280-26-034580 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 1.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 456,886 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 52.1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 13,317 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 11,404 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 32,360 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 3.6 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 2.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 597,621 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 43.1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 3.38M | 2018-12-31 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 200,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003767 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 0 | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022342 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 6.3 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 93.52 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 15.7 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 4.45 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | SharePrice | Share Price | USD/shares | 17.2 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 2.085 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 92.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 169.32M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0000950170-23-006264 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 38,298 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 50.00M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 13,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 5.14M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 21,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0001739410-24-000035 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 84,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-09 | 0000950170-21-001740 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 241,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001628280-26-018261 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | |||
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 2.50M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-08-26 | 0001193125-26-368568 | ||
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 5.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 30.32M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009013 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 5.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-27 | 0001628280-26-067422 |